UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer

Clinical cancer research, 2015-08, Vol.21 (16), p.3658-3666

2015

Link zum Volltext

Verfügbarkeit prüfen

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer

Breast cancer research : BCR, 2021-03, Vol.23 (1), p.30-12, Article 30

2021

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Locally Advanced Head-and-Neck Cancer

International journal of radiation oncology, biology, physics, 2009-02, Vol.73 (2), p.410-415

2009

Link zum Volltext

Verfügbarkeit prüfen

Traditional risk factors and cancer-related factors associated with cardiovascular disease risk in head and neck cancer patients

Frontiers in cardiovascular medicine, 2023-01, Vol.9, p.1024846-1024846

2023

Link zum Volltext

Verfügbarkeit prüfen

Locoregionally Advanced Head and Neck Cancer Treated With Primary Radiotherapy: A Comparison of the Addition of Cetuximab or Chemotherapy and the Impact of Protocol Treatment

International journal of radiation oncology, biology, physics, 2008-07, Vol.71 (3), p.676-681

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced Cancers

Clinical cancer research, 2010-03, Vol.16 (6), p.1924-1937

2010

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies

Radiation oncology (London, England), 2012-12, Vol.7 (1), p.219-219, Article 219

2012

Link zum Volltext

Verfügbarkeit prüfen

Racial and rural–urban disparities in cardiovascular risk factors among patients with head and neck cancer in a clinical cohort

Head & neck, 2022-07, Vol.44 (7), p.1563-1575

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma

Clinical cancer research, 2024-01, Vol.30 (1), p.63

2024

Link zum Volltext

Verfügbarkeit prüfen

Induction chemotherapy for head and neck cancer: is there still a role?

Future oncology (London, England), 2016-07, Vol.12 (13), p.1595-1608

2016

Link zum Volltext

Verfügbarkeit prüfen

BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors

Future oncology (London, England), 2022-09, Vol.18 (29), p.3245-3254

2022

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer. Clinical practice guidelines in oncology

Journal of the National Comprehensive Cancer Network, 2009-02, Vol.7 (2), p.122

2009

Link zum Volltext

Verfügbarkeit prüfen

Geographical and Racial Disparities in Head and Neck Cancer Diagnosis in South-Eastern United States: Using Real-World Electronic Medical Records Data

Health equity, 2020-03, Vol.4 (1), p.43-51

2020

Link zum Volltext

Verfügbarkeit prüfen

Less Toxic Chemotherapy in Locally Advanced Breast Cancer

Southern medical journal (Birmingham, Ala.), 2020-11, Vol.113 (11), p.559

2020

Link zum Volltext

Verfügbarkeit prüfen

Targeted Expression of a Dominant Negative Epidermal Growth Factor Receptor in the Mammary Gland of Transgenic Mice Inhibits Pubertal Mammary Duct Development

Molecular endocrinology (Baltimore, Md.), 1997-11, Vol.11 (12), p.1766-1781

1997

Link zum Volltext

Verfügbarkeit prüfen

NCCN Guidelines Insights: Antiemesis, Version 2.2017

Journal of the National Comprehensive Cancer Network, 2017-07, Vol.15 (7), p.883

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer

Head & neck, 2011-11, Vol.33 (11), p.1551-1556

2011

Link zum Volltext

Verfügbarkeit prüfen

NCCN Task Force Report: breast cancer in the older woman

Journal of the National Comprehensive Cancer Network, 2008, Vol.6 Suppl 4, p.S1

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term results of a phase I/II trial of the addition of celecoxib to chemoradiotherapy for locally advanced or recurrent squamous cell carcinoma of the head-and-neck

Journal of radiation oncology, 2016-12, Vol.5 (4), p.363-369

2016

Link zum Volltext

Verfügbarkeit prüfen

By the pricking of my thumbs, something wicked this way comes: sporadic cancers versus eponymous hereditary cancer predisposition syndromes

Journal of the National Comprehensive Cancer Network, 2012-01, Vol.10 (1), p.7

2012

Link zum Volltext

Verfügbarkeit prüfen

Racial and rural-urban disparities in cardiovascular risk factors among head and neck cancer patients in a clinical cohort

Head & neck, 2022-04, Vol.44 (7), p.1563-1575

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 16935: Cardiovascular Disease in Head Neck Squamous Cell Carcinoma Patients - A Case-Control Study Using Electronic Medical Records Data

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A16935-A16935

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS10-30: An open label, pilot study of veliparib and lapatinib in patients with metastatic, triple negative breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS10-30-PS10-30

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Study of Erlotinib Plus Radiation Therapy in Patients With Advanced Cutaneous Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2013-04, Vol.85 (5), p.1275-1281

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Englisch
(44)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(30)
Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Female
(22)
Oncology
(20)
Middle Aged
(18)
Male
(15)
Adult
(14)
Aged
(14)
Aged, 80 And Over
(9)
Chemotherapy
(9)
Neoplasm Staging
(9)
Patients
(8)
Radiotherapy
(8)
Treatment Outcome
(8)
Antineoplastic Agents - Therapeutic Use
(7)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(7)
Breast Neoplasms - Pathology
(7)
Surgery
(7)
Tumors
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer

Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Locally Advanced Head-and-Neck Cancer

Traditional risk factors and cancer-related factors associated with cardiovascular disease risk in head and neck cancer patients

Locoregionally Advanced Head and Neck Cancer Treated With Primary Radiotherapy: A Comparison of the Addition of Cetuximab or Chemotherapy and the Impact of Protocol Treatment

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced Cancers

Prognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies

Racial and rural–urban disparities in cardiovascular risk factors among patients with head and neck cancer in a clinical cohort

Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma

Induction chemotherapy for head and neck cancer: is there still a role?

BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors

Breast cancer. Clinical practice guidelines in oncology

Geographical and Racial Disparities in Head and Neck Cancer Diagnosis in South-Eastern United States: Using Real-World Electronic Medical Records Data

Less Toxic Chemotherapy in Locally Advanced Breast Cancer

Targeted Expression of a Dominant Negative Epidermal Growth Factor Receptor in the Mammary Gland of Transgenic Mice Inhibits Pubertal Mammary Duct Development

NCCN Guidelines Insights: Antiemesis, Version 2.2017

Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer

Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor— or Progesterone Receptor—Positive Breast Cancer

NCCN Task Force Report: breast cancer in the older woman

Long-term results of a phase I/II trial of the addition of celecoxib to chemoradiotherapy for locally advanced or recurrent squamous cell carcinoma of the head-and-neck

By the pricking of my thumbs, something wicked this way comes: sporadic cancers versus eponymous hereditary cancer predisposition syndromes

Racial and rural-urban disparities in cardiovascular risk factors among head and neck cancer patients in a clinical cohort

Abstract 16935: Cardiovascular Disease in Head Neck Squamous Cell Carcinoma Patients - A Case-Control Study Using Electronic Medical Records Data

Abstract PS10-30: An open label, pilot study of veliparib and lapatinib in patients with metastatic, triple negative breast cancer

Phase 1 Study of Erlotinib Plus Radiation Therapy in Patients With Advanced Cutaneous Squamous Cell Carcinoma

Suchergebnisse filtern